| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |